Individuals who have been recognised by the society, to have made an extraordinary contribution to toxicology and poisons network in Australasia. Honorary members are eligible to vote and be elected to council.
The following persons were awarded Honorary Membership in 2022 at the ASM.
Nick Buckley is a clinical pharmacologist and toxicologist whose research has focused on toxicology from a range of perspectives including systematic reviews, clinical trials, drug development, public health interventions, biomarkers and clinical epidemiology. He has been awarded research grants totaling over $23 million and has published over 350 papers in refereed journals since 1993 (h-index = 63; Google Scholar). He also holds a range of advisory and editorial roles that actively translate research findings into practice. Professor Buckley is Chair of the Editorial Advisory Board of the Australian Medicines Handbook, Past President of Asia Pacific Association of Medical Toxicology, member of national Advisory Committee on Safety of Medicines and a consultant clinical toxicologist to the Poisons Information Centres in Australia.
Nick is pictured on the right of the picture with Kerry Hoggett (left), outgoing TAPNA President (2022) and Adam Pomerlau (middle), Incoming TAPNA President.
Andrew Dawson is a clinical pharmacologist and toxicologist with major interest in public health, addiction medicine and research translation. He holds peak clinical positions within Australia including clinical director of the NSW Poisons Information Centre and has extensive experience of establishing collaborative research groups His major contributions have been developing infrastructure and collaboration for 3 major research groups, Hunter Area Toxicology (HATS), SACTRC and PICs for the Australian Toxicology Monitoring projects. Most recently the establishement of joint positions and research with NSW Public Health. His internationally recognized translational toxicosurveillance research has been translated into policy leading to the restriction or banning of a number of pharmaceuticals and agrochemicals with significant reduction in deaths from suicide. The capacity building collaborative research network he established in Sri Lanka (SACTRC) is considered unique and has been successfully transitioned to local leadership. He has over 180 publications, which are widely cited in textbooks and international guidelines. His epidemiological research. He has established affordable globally delivered online teaching programs for clinical toxicology.
Andrew was unable to attend the conference in person to receive his award, but joined on Zoom.
Michael Downes is a FACEM and clinical toxicologist, despite his Scottish background and poor taste in football teams, he trained in Newcastle in Clinical Toxicology in 2003 and 2004 at the Mater, and has been a consultant for HATS since 2005. He has a particular interest in Toxicology training and is a part of the Clinical Toxicology Research Group at the University of Newcastle. He established training courses for the full range of health care workers in Australia, as well as in a number of resource poor countries including Sri Lanka. From nurses to toxicology trainees, he has organised toxicology courses from the first TAPNA meeting. He was the major driving force behind TAPNA, including the first two meetings in Newcastle in 2013 and 2014. He continued organising meetings in other cities and was the first President of TAPNA.
Michael pictured (right), accepting his award. Pictured with Kerry Hoggett (middle), outgoing TAPNA President (2022) and Adam Pomerlau (left), Incoming TAPNA President.
Geoff Isbister is a clinical toxicologist and clinician researcher, with a major interest in envenoming and poisoning. He is a Professor and NHMRC Senior Research Fellow (2014+) at the University of Newcastle and a Consultant Toxicologist at the Calvary Mater Newcastle and National Poison Centre Network. He has won numerous awards for his research, including the Australasian Society and Clinical and Experimental Pharmacology and Toxicology Achievement award in 2013; and an Order of Australia in 2019. He has been awarded research grants totaling over $20 million and has published over 300 papers in refereed journals since 2000 (h-index = 59; Google Scholar). He is regularly invited to speak at national and international meetings and is on a number of journal editorial boards including as a Senior Editor of the British Journal of Clinical Pharmacology, in which he has edited a special issue on therapeutics in clinical toxicology in 2016.
Geoff pictured (right), accepting his award. Pictured with Kerry Hoggett (left), outgoing TAPNA President and Adam Pomerlau (middle), Incoming TAPNA President.